A stochastic model for COVID-19 spread and the effects of Alert Level 4 in Aotearoa New Zealand
暂无分享,去创建一个
Michael J. Plank | Audrey Lustig | Alex James | Rachelle N. Binny | Shaun C. Hendy | Nicholas Steyn | M. Plank | A. Lustig | A. James | S. Hendy | N. Steyn | R. Binny | Audrey Lustig
[1] P. Klepac,et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[2] N. G. Davies,et al. The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study , 2020, medRxiv.
[3] Axel Gandy,et al. Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in European countries: technical description update , 2020, 2004.11342.
[4] Lucie Abeler-Dörner,et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.
[5] Nick Wilson,et al. Modelling the Potential Health Impact of the COVID-19 Pandemic on a Hypothetical European Country , 2020, medRxiv.
[6] S. Bhatt,et al. Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .
[7] Christel Faes,et al. Estimating the generation interval for COVID-19 based on symptom onset data , 2020, medRxiv.
[8] P. E. Kopp,et al. Superspreading and the effect of individual variation on disease emergence , 2005, Nature.
[9] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[10] Centers for Disease Control and Prevention CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[11] Further Particulars,et al. London School of Hygiene & Tropical Medicine , 2007 .
[12] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[13] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[14] M. Plank,et al. Suppression and Mitigation Strategies for Control of COVID-19 in New Zealand , 2020, medRxiv.
[15] N. G. Davies,et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.
[16] S. Eubank,et al. Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand” , 2020, Bulletin of Mathematical Biology.
[17] N. Steyn,et al. Effect of Alert Level 4 on effective reproduction number: review of international COVID-19 cases , 2020, medRxiv.
[18] C. Whittaker,et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .